Two lawmakers have accused three generic drugmakers of "coordinated obstruction" and "apparent efforts to stonewall" a 2014 probe into their pricing strategies, according to CNBC. 

The FDA has approved Pretomanid, an oral tablet for highly treatment-resistant forms of tuberculosis of the lungs. 

Page Bouchard was named senior vice president and chief scientific officer of AveXis, the gene therapy unit of Novartis wrapped in a scandal over manipulated data, according to Endpoints News. Mr. Bouchard is replacing two top scientists at the company,…

Illinois Gov. JB Pritzker signed a bill into law that will require insurers to cover the costs of EpiPen injectors for children, according to CNN. 

Genealogy company Ancestry is planning a push into healthcare, according to Business Insider.

The Institute for Clinical and Economic Review, a U.S. pricing watchdog, has proposed changing its evaluation process to better account for CAR-T and gene therapy prices, according to an S&P Global Market Intelligence report. 

U.S. Senate Finance Committee Chairman Chuck Grassley, R-Iowa, has asked Novartis to provide company records and details about data manipulation related to FDA approval of its $2 million gene therapy Zolgensma, according to EndPoints News.

An Oklahoma pharmacy owner has pleaded guilty to taking part in a $1.1 million scheme that defrauded health insurance providers, according to KFOR-TV.

Walmart soon will open a 1,500-square-foot retail space and pharmacy in a Toyota plant in Mississippi, according to the Daily Journal. 

Several drugs entered the U.S. market in 2019, some of which could generate at least $1 billion in annual sales by 2024, according to market research firm EvaluatePharma.